Effect of neucleoplasty in management of prolapsed intervertebral disc disease
Phase 4
- Conditions
- Health Condition 1: M479- Spondylosis, unspecified
- Registration Number
- CTRI/2019/03/018159
- Lead Sponsor
- ESI Institute of Pain Management
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
2.Symptomatic prolapsed intervertebral disc disease with VAS score more than 7 after walking or standing for 15 minutes.
3.Already treated for 3 months with antineuropathic medicines without satisfactory improvement, failed conservative therapy.
4.In MRI there is prolapsed intervertebral disc & disc height is maintained (more than 50%).
5.Patients who did not want open neurosurgery and give consent for nucleoplasty and minimal disk intervention.
Exclusion Criteria
1.Patients with motor deficit or significant sensory loss or bladder bowel involvement.
2.Cauda equina syndrome
3.Severe spinal canal stenosis
4.Loss of disk height > 50%.
5.Spinal fracture or tumor
6.Patients who want neurosurgery.
7.Coagulopathy
8.Local skin infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain in NRS scoreTimepoint: before Neucleoplasty and after 2 weeks, 3 months & 6 months after procedure
- Secondary Outcome Measures
Name Time Method functional disability in Ronald Morris Disability Questionnaire ScoreTimepoint: before Neucleoplasty and after 2 weeks, 3 months & 6 months after procedure